Joseph T. Beck
Joseph T. Beck publishes mostly in Oncology, Pulmonary and Respiratory Medicine and Genetics, on topics such as Advanced Breast Cancer Therapies, Glioma Diagnosis and Treatment and HER2/EGFR in Cancer Research.
- World rank
- #3,900,766 of 7,710,434 ranked researchers
- Rank in United States
- #1,069,321 of 1,627,098
- Works
- 18
- Citations
- 420
- Citations per work
- 23.3
What does Joseph T. Beck research?
Joseph T. Beck's work is mostly in Medicine (63%), Biochemistry, Genetics and Molecular Biology (6%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences1162.7%
- Medicine1162.7%
- Everything else631.4%
- Life Sciences15.9%
- 1Oncology26% of their works
- 2Pulmonary and Respiratory Medicine20% of their works
- 3Genetics10% of their works
- 4Cancer Research6% of their works
- 5Public Health, Environmental and Occupational Health4% of their works
- 6Hematology4% of their works
Research topics
Which keywords describe Joseph T. Beck's research?
The keywords of their largest research topics: Breast Cancer, Targeted Therapy, CDK4/6 Inhibitors, Palbociclib, ALK Inhibitors, EGFR Mutations, Glioblastoma and HER2.
- PD-1 and PD-L1
- Immune Checkpoint Blockade
- Genomic Aberrations
- Cancer Genomics
- Trastuzumab
- HER2
- EGFR Mutations
- Palbociclib
- Targeted Therapy
- Breast Cancer
- CDK4/6 Inhibitors
- ALK Inhibitors
- Glioblastoma
- Temozolomide
- BCR-ABL
- Chronic Lymphocytic Leukemia
- Imatinib
- Mutational Signatures
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most.
All 18 words, with their numbers
- Breast Cancer72 topics
- Targeted Therapy52 topics
- CDK4/6 Inhibitors41 topic
- Palbociclib41 topic
- ALK Inhibitors31 topic
- EGFR Mutations31 topic
- Glioblastoma31 topic
- HER231 topic
- Temozolomide31 topic
- Trastuzumab31 topic
- BCR-ABL21 topic
- Cancer Genomics21 topic
- Chronic Lymphocytic Leukemia21 topic
- Genomic Aberrations21 topic
- Imatinib21 topic
- Immune Checkpoint Blockade21 topic
- Mutational Signatures21 topic
- PD-1 and PD-L121 topic
Where does Joseph T. Beck work?
Joseph T. Beck's main affiliation in the publication record is Highlands Oncology Group, United States.
How many publications and citations does Joseph T. Beck have?
OpenAlex counts 18 works and 420 citations for Joseph T. Beck, an h-index of 9, ranking #3,900,766 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Joseph T. Beck. Posts are plain text and can be reported.